Drug Trial Radar · NCT05143957
A Study to Evaluate Sapablursen (Formerly ISIS 702843, IONIS-TMPRSS6-LRx) in Patients With Polycythemia Vera
Last checked: Nov 19, 2026Latest source record: Jul 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
50
Actual
Start
Dec 30, 2021
Primary completion
Jun 26, 2025
Study completion Jun 2, 2026
Sponsor
- Lead sponsor
- Ionis Pharmaceuticals, Inc.Ionis Pharmaceuticals (IONS)
- Sponsor type
- Industry
- First posted
- Dec 3, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study is to evaluate the efficacy of sapablursen in reducing the frequency of phlebotomy and in improving quality of life assessments in participants with polycythemia vera.
Conditions
- Phlebotomy Dependent Polycythemia Vera
Interventions
sapablursenDrug
Sapablursen will be administered by SC injection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in the frequency of phlebotomy comparing Baseline with the last 20 weeks of the 37 week Treatment PeriodTime frame: Week 17 to Week 37
Locations
13 sites in 5 countries. Site status is shown where the registry gives one.
O'Neal Comprehensive Cancer Center University of Alabama at Birmingham
Birmingham, Alabama
Mayo Clinic Hospital
Phoenix, Arizona
John Theurer Cancer Center
Hackensack, New Jersey
Cleveland Clinic Foundation
Cleveland, Ohio
University of Texas MD Anderson Cancer Center
Houston, Texas
Border Medical Oncology Research Unit
Albury, Australia
Calvary Mater Newcastle Hospital
Waratah, New South Wales, Australia
McGill University Health Centre
Montreal, Quebec, Canada
Samodzielny Publiczny Szpital Kliniczny Nr 1 w Lublinie, Klinika Hematoonkologii i Transplantacji Szpiku
Lublin, Poland
Wojewódzki Szpital Specjalistyczny Sp. z o.o.
Słupsk, Poland
MICS Centrum Medyczne Toruń
Torun, Poland
University College London Hospitals NHS Foundation Trust
London, United Kingdom
Oxford University Hospitals NHS Foundation Trust
Oxford, England, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.